Oncomedics is a biotechnology company specialising in the personalisation of cancer treatments.

We are developing in vitro diagnostic medical devices that provide decision support to practitioners (surgeons, pathologists and oncologists) in order to identify the most effective treatments to cure a patient.

Founded in 2006 by Christophe Lautrette and Stéphanie Giraud, Oncomedics has its own laboratory and production unit in Limoges (Nouvelle-Aquitaine, France). Oncomedics has established numerous solid collaborations with clinical centres (AP-HP, HCL, Institut Bergonié), academic laboratories (Paris, Lyon, Marseille), pharmaceutical industries (Ipsen, Sanofi... ) and biotechnology companies (Oncodesign).